论文部分内容阅读
目的:对沙丁胺醇气雾剂和异丙托溴铵气雾剂联用治疗慢性阻塞性肺病的临床疗效进行研究,为临床提供参考。方法:选取本院收治的65例慢性阻塞性肺病患者作为研究对象,随机将其分成实验组和对照组,观察两组患者的临床疗效。结果:实验组患者的总改善率为96.00%;对照组患者的总改善率为82.00%,实验组患者的总改善率明显高于对照组患者,实验组与对照组比较,p<0.05,差异具有统计学意义。结论:沙丁胺醇气雾剂和异丙托溴铵气雾剂联用治疗慢性阻塞性肺病的临床疗效显著,值得应用并推广。
OBJECTIVE: To study the clinical efficacy of salbutamol aerosol and ipratropium bromide aerosol in the treatment of chronic obstructive pulmonary disease (COPD), and to provide a reference for clinical practice. Methods: Sixty-five patients with chronic obstructive pulmonary disease (COPD) admitted to our hospital were selected as study subjects and randomly divided into experimental group and control group. Clinical efficacy of the two groups were observed. Results: The total improvement rate of the experimental group was 96.00%; the total improvement rate of the control group was 82.00%, the total improvement rate of the experimental group was significantly higher than that of the control group, the experimental group and the control group, p <0.05, the difference has statistical significane. Conclusion: The salbutamol aerosol and ipratropium bromide aerosol combination therapy for chronic obstructive pulmonary disease clinical efficacy is significant, it is worth to apply and promote.